Antimicrobial Resistance Surveillance Market to Reach USD 9.50 Billion by 2032
The Antimicrobial Resistance Surveillance Market, valued at USD 5.90 billion in 2023 and projected to reach USD 9.50 billion by 2032 with a CAGR of 5.47%, plays a crucial role in combating the global public health crisis posed by antimicrobial resistance (AMR). AMR, responsible for approximately 700,000 deaths annually, involves pathogens like bacteria and fungi evolving to resist life-saving drugs.